Thermo Fisher Scientific reported a strong start to the year with first-quarter earnings surpassing Wall Street expectations. The company posted adjusted earnings per share (EPS) of $5.11, significantly higher than the estimated $4.71. Revenue also exceeded forecasts, reaching $10.34 billion against expectations of $10.16 billion. Following these results, Thermo Fisher raised its full-year guidance, now expecting adjusted EPS to be between $21.14 and $22.02, up from the previous range of $20.95 to $22.00, and forecasting revenues between $42.3 billion and $43.3 billion. The company's market cap stands at $219.33 billion. CEO stated, 'We are very pleased to deliver another quarter of strong financial results. We had a great start to the year...'
Thermo Fisher Scientific TMO lifts guidance after topping Q1 expectations https://t.co/F4e4tHFs0G https://t.co/GpTXqDP7WF
⚠️ THERMO FISHER LIFTS PROFIT FORECAST AS MEDICAL EQUIPMENT DEMAND IMPROVES Full Story → https://t.co/ZjOp6hgnjw Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and… https://t.co/K2S4CwR0mF
$TMO | Thermo Fisher Scientific Q1 Earnings: - Adj EPS $5.11 (Est. $4.71) 🟢 - Sales $10.340B (Est. $10.170B) 🟢 - Raises FY2024 Outlook - Sees FY24 Adj EPS $21.40-$22.02 ($20.95-22.00 Prior) (Est. $21.53) - Sees FY24 Sales $42.3B-$43.3B ($42.1B-43.3B Prior) (Est. $42.83B) https://t.co/J3dRCNDTNA
Thermo Fisher Scientific double beat. CEO: "We are very pleased to deliver another quarter of strong financial results. We had a great start to the year..." $TMO: +0.4% PM https://t.co/9f3IVWMmRZ
$TMO Thermo Fisher beats, raises FY guidance https://t.co/DunfU9hgyP
💰 Thermo Fisher Scientific $TMO EPS. vs Forecast 5.11 / 4.71 🟢 Rev. vs Forecast 10.34B / 10.16B 🟢 Market Cap: 219.33B
$TMO | Thermo Fisher Scientific Q1 24 Earnings: - Adj EPS: $5.11 (est $4.71) - Revenue $10.34B (est $10.17B) - Sees FY Adj EPS $21.14 To $22.02, Saw $20.95 To $22 - Sees FY Rev $42.3B To $43.3B, Saw $42.1B To $43.3B